Improves cholesterol levels In the SURPASS-4 clinical trial, tirpatide (15 mg dose): Reduced total cholesterol by 6% Reduced LDL (bad cholesterol) by 8% Reduced triglycerides by 23% Boosted HDL (good cholesterol) by 11% Increases satiety and reduces hunger Tirzepatide stimulates GLP-1 and GIP receptors, improves insulin sensitivity, increases satiety, and slows the rate at which food moves from the stomach into the intestines
Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M , Marini F
Not only are these drugs tackling metabolic diseases, but according to Ricks, they're also beneficial in reducing inflammation
Fibropolycystic liver disease: CT and MR imaging findings
chevron_left chevron_right What is retatrutide and what sets it apart Retatrutide could be a first in the obesity/overweight and type 2 diabetes mellitus (T2DM) space, by using the triple G mechanism (GLP-1, glucose-dependent insulinotropic polypeptide [GIP] and glucagon receptors)